Symeres announces the evolution of its leadership team ahead of the company’s next phase of development. After nearly three decades at the helm, Symeres’ co-founders, Dr. Eelco Ebbers (CEO) and Dr. Frank Leemhuis (Head of Corporate Development), have decided to step back from their current executive roles.
Guillaume Jetten, a long-time member of the Executive Board alongside the founders, has been appointed as CEO. Eelco and Frank will remain in their roles until January 2025, with both founders providing ongoing support to Guillaume thereafter to ensure continuity. Eelco will join the Supervisory Board and Frank will be an advisor to the Supervisory Board.
Alongside this management evolution, Symeres is announcing two further appointments to the Executive Board. Edo van Houten will join Symeres as CFO having held similar roles at several CRO and CDMO companies in the Netherlands. Philip Payne will join Symeres as Chief Commercial Officer (CCO). Philip has extensive experience in CCO roles with several CRO and CDMO companies. In addition, Russell Thomas, currently the Head of Business Development, will take on the role of Chief Scientific Officer (CSO), leading on key client and partner relationships and opportunities in scientific development.
Read the full press release here.
